相关实验视频
Updated: Sep 17, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
371
在类风湿性关节炎免疫性突触中STAT3酸化
Hila Novak-Kotzer1, Jesusa Capera2, Ashwin Jainarayanan2
1Skirball Institute of Biomolecular Medicine, NYU Langone Medical Center, New York, NY, 10016, USA; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, OX3 7FY, UK.
Journal of autoimmunity
|July 3, 2025
概括
发现了一种新的JAK独立途径,通过免疫突触激活T细胞中的STAT3. 这条涉及LCK和TCR的途径在类风湿性关节炎 (RA) 中受损,为耐药患者提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 细胞信号传输 细胞信号传输
背景情况:
- 准简氏激酶/信号转换器和转录激活器 (JAK/STAT) 途径是风湿性关节炎 (RA) 的首要策略.
- 雅克抑制剂是有效的,但RA患者的一个子集对这种疗法没有反应,需要替代治疗.
研究的目的:
- 在T细胞中识别独立于JAK信号的STAT3激活的新机制.
- 研究免疫突触 (IS) 在T细胞激活中的作用及其对RA病变的潜在相关性.
主要方法:
- 在免疫突触形成期间,对原始CD4+T细胞中STAT3激活的分析.
- 研究LCK (淋巴细胞特异性蛋白质氨酸激酶) 和TCR (T细胞受体) 在IS的STAT3酸化中的作用.
- 在健康个体和RA患者中比较突触LCK/TCR-STAT3通路.
主要成果:
- 确定了一种新的JAK-独立的STAT3激活途径,由原始CD4+T细胞中IS形成触发.
- 证实LCK能够在IS中调解TCR依赖的STAT3酸化,这代表了T细胞早期激活的关键事件.
- 在风湿性关节炎患者中,突触LCK/TCR-STAT3通路被发现受损.
结论:
- 免疫突触中的LCK/TCR-STAT3通路是T细胞激活的以前未知的机制.
- 这一途径代表了类风湿性关节炎的潜在治疗标,特别是对于抗JAK抑制剂耐药的患者.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K

